Should the patient be treated with continuous renal replacement therapy (CRRT) or prolonged intermittent renal replacement therapy (PIRRT)?

CRRT vs PIRRT: Clinical Decision Framework

Both CRRT and PIRRT are equally effective modalities for critically ill patients with AKI, with no clear survival advantage of one over the other—choose based on hemodynamic stability needs, resource availability, and institutional expertise. 1

Primary Recommendation

The most recent guideline evidence (2021 ESPEN) explicitly states: "No clear advantage has been demonstrated so far for CKRT over PIKRT" 1. This is further supported by the 2017 Surviving Sepsis Campaign guidelines, which provide only a weak recommendation for either modality 2.

Decision Algorithm

Step 1: Assess Hemodynamic Status

• Hemodynamically unstable patients (requiring vasopressors, MAP fluctuations):

  • Prefer CRRT or PIRRT over standard intermittent hemodialysis 1
  • Both provide better hemodynamic stability, slower solute shifts, and superior fluid removal tolerance 1
  • PIRRT can be safely used as an alternative to CRRT in hemodynamically unstable adult patients 3

• Hemodynamically stable patients:

  • Standard intermittent hemodialysis is acceptable 1
  • PIRRT offers flexibility with 6-12 hour sessions, 4-7 times weekly 4

Step 2: Consider Specific Clinical Scenarios

Choose CRRT (or PIRRT as equivalent alternative) for:

• Acute brain injury with increased intracranial pressure 3
• Generalized brain edema (slower solute flux reduces risk of cerebral edema) 3
• Severe fluid overload requiring continuous removal 1
• High catabolic states needing continuous clearance 1

Step 3: Evaluate Resource Constraints

PIRRT advantages:

• Cost-effective compared to CRRT 5, 6, 7
• Allows early patient mobilization 6
• Decreased nursing time requirements 6
• Can be delivered using either CRRT machines or intermittent HD machines 4
• Does not require 24-hour ICU nursing dedication 4

CRRT considerations:

• Requires continuous anticoagulation (citrate preferred when available) 8
• Higher resource utilization 6
• May not be available in all centers 9

Step 4: Dosing Parameters

For CRRT:

• Target effluent volume: 20-25 mL/kg/hour 2, 8
• Recent evidence suggests lower doses (12.5 mL/kg/hour) may be equivalent in selected patients 10

For PIRRT:

• Duration: 6-12 hours per session 4
• Frequency: 4-7 times per week 4
• Blood flow: approximately 310 mL/min 11
• Delivers comparable dose to CRRT when properly prescribed 5, 11

For intermittent HD (if used):

• Kt/V of at least 1.2 per treatment, 3 times weekly 8

Key Evidence Synthesis

The 2013 KDOQI commentary specifically notes that "PIRRT modalities can be safely used in hemodynamically unstable adult patients" and calls for additional research comparing effectiveness and cost 3. The Canadian Society of Nephrology (2013) found PIRRT (SLED) offers "comparable results to CRRT in terms of hemodynamic stability" 9.

Recent research (2012-2023) consistently demonstrates:

• No mortality difference between CRRT and PIRRT 5, 6, 7
• Similar renal recovery rates 5, 10
• PIRRT is non-inferior to CRRT for patient outcomes 6

Critical Pitfalls to Avoid

1. Don't assume CRRT is superior: Despite theoretical advantages, RCTs show no survival benefit over intermittent or prolonged intermittent modalities 2

2. Account for delivered vs. prescribed dose: Patients typically receive only 68-85% of prescribed CRRT dose due to interruptions 9. PIRRT may deliver more consistent dosing.

3. Avoid standard intermittent HD in specific populations: Patients with hemodynamic instability, brain injury, or severe fluid overload require prolonged modalities 1, 3

4. Consider drug dosing challenges: PIRRT lacks standardization, making medication dosing more complex 6

5. Pediatric patients: Experience with PIRRT is extremely limited in children; CRRT remains preferred 3

Practical Implementation

In centers with both modalities available: PIRRT represents a pragmatic first choice for most critically ill AKI patients, offering equivalent outcomes with lower resource utilization 5, 6, 4. Reserve CRRT for patients requiring truly continuous therapy (severe refractory fluid overload, extreme hemodynamic instability unresponsive to PIRRT).

In centers without CRRT capability: PIRRT enables RRT delivery in facilities with dialysis capability but not 24-hour CRRT infrastructure, potentially avoiding unnecessary transfers 9.

The choice ultimately depends on institutional expertise, available resources, and nursing capabilities rather than inherent superiority of one modality 8, 4.